Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,252 | 29,965 | 36,296 | 42,565 | 47,122 |
| Other current assets | 0 | 46 | 0 | 115 | 49 |
| TOTAL | $41,361 | $31,511 | $38,079 | $43,171 | $47,638 |
| Non-Current Assets | |||||
| PPE Net | 1,086 | 1,092 | 905 | 327 | 177 |
| Other Non-Current Assets | 1,250 | 1,675 | 1,344 | 51 | 51 |
| TOTAL | $2,336 | $2,767 | $2,249 | $378 | $228 |
| Total Assets | $43,697 | $34,278 | $40,328 | $43,549 | $47,866 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,297 | 3,979 | 2,520 | 1,604 | 1,213 |
| Accrued Expenses | 3,387 | 3,371 | 3,348 | 3,056 | 830 |
| Other current liabilities | 522 | 659 | 939 | N/A | N/A |
| TOTAL | $8,206 | $8,009 | $6,807 | $4,660 | $2,043 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,071 | 1,112 | 1,153 | 0 | 0 |
| TOTAL | $1,071 | $1,112 | $1,153 | $N/A | $N/A |
| Total Liabilities | $9,277 | $9,121 | $7,960 | $4,660 | $2,043 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,127 | 983 | 979 | 979 | 978 |
| Common Shares | 18 | 16 | 16 | 16 | 16 |
| Retained earnings | -48,413 | -39,395 | -30,924 | -23,720 | -16,645 |
| TOTAL | $34,420 | $25,157 | $32,368 | $38,889 | $45,823 |
| Total Liabilities And Equity | $43,697 | $34,278 | $40,328 | $43,549 | $47,866 |